ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1029

Improving Gout Outcomes Using a Disease Management Program within an Integrated Health System

David Bulbin1, Carson Maynard2, Tarun Sharma1, Alfred E. Denio3, Jason Brown4, Andrea Berger5, H. Lester Kirchner5 and William T. Ayoub6, 1Rheumatology, Geisinger Medical Center, Danville, PA, 2Internal Medicine, Geisinger Medical Center, Danville, PA, 3Dept of Rheumatology, Geisinger Medical Center, Danville, PA, 4Henry Hood Center for Clinical Research, Geisinger Health System, Danville, PA, 5Biostatistics, Geisinger Center for Health Research, Danville, PA, 6Rheumatology, Geisinger Medical Group, State College, PA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Gout and quality improvement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Quality Measures and Quality of Care

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Gout is a chronic inflammatory arthritis which can be effectively managed.  The American College of Rheumatology published evidenced based gout management guidelines. These guidelines are often not followed leading to unnecessary morbidity and cost. We piloted a gout management quality improvement project at one primary care site and the rheumatology department within our integrated health system.

Methods:  The primary care site included 3 internal medicine providers, 11 family medicine providers, and 441 gout patients.  We surveyed primary care providers for their preferred quality improvement strategies. These strategies included live or online continuing medical education (CME), electronic medical record reminders, nursing staff protocols, and a monthly National Quality Forum based outcome measure report card for each provider comparing their performance with peers. The Rheumatology Department included 15 rheumatologists and 800 gout patients.  An exit survey again asked for the providers’ preferred quality improvement strategies. Lastly, we compared the intervention primary care clinic results to a usual care control: another clinic that was matched for providers and gout patients. Performance data for gout patients 6 months before and after intervention were compared.  Binary logistic regression models were used to obtain estimates of odds ratios with their 95% confidence intervals (CI). Post-intervention performance in the pilot site was compared to the control site.

Results: Data analysis pre- and post- intervention is presented in Table 1. Odds Ratios with their 95% confidence intervals for primary care intervention site versus usual care control are presented in figures 1 and 2.  Survey results showed primary care providers rated live CME and electronic health record reminders the highest with an average 4/5 (5 being most effective).  Rheumatologists chose audit and feedback of their own performance compared with peers highest at 4/5.

Conclusion: Gout management significantly improved with primary care and rheumatology intervention, education and accountability.  There were significant improvements in both monitoring (P<0.0001) and goal uric acid level (P<0.0001).   Gout outcome measures improved significantly in the intervention primary care site compared to the usual care site. The provider survey suggests that CME, EHR reminders and report card feedback were the most effective at changing provider behavior. We plan a system wide implementation of this gout quality improvement project.

 

Table 1: Odds Ratios and their 95% Confidence Intervals for Comparisons

 

OR

95% CI

P-value

Lower Bound

Upper Bound

Primary Care Intervention Site: Average Effect Post Intervention vs. Average Effect Pre-Intervention

 

 

 

 

Treated with urate lowering therapy

1.16

1.04

1.30

0.0089

Monitored Uric Acid in past 2 years

3.76

3.17

4.45

< 0.0001

At Goal (Uric Acid < 6.0)

2.44

2.01

2.96

< 0.0001

 

 

 

 

 

Rheumatology: Average Effect Post Intervention vs. Average Effect Pre-Intervention

 

 

 

 

Treated with urate lowering therapy

1.07

0.95

1.22

0.2539

Monitored Uric Acid in past 2 years

5.67

5.08

6.33

< 0.0001

At Goal (Uric Acid < 6.0)

3.16

2.88

3.48

< 0.0001

 

 

 

 

 

Primary Care Intervention Site vs. Usual Care Control Site for May 2015 Performance

 

 

 

 

Treated with urate lowering therapy

1.37

1.03

1.83

0.0329

Monitored Uric Acid in past 2 years

3.32

2.18

5.06

< 0.0001

At Goal (Uric Acid < 6.0)

1.94

1.29

2.91

0.0014


Disclosure: D. Bulbin, None; C. Maynard, None; T. Sharma, None; A. E. Denio, None; J. Brown, None; A. Berger, None; H. L. Kirchner, None; W. T. Ayoub, None.

To cite this abstract in AMA style:

Bulbin D, Maynard C, Sharma T, Denio AE, Brown J, Berger A, Kirchner HL, Ayoub WT. Improving Gout Outcomes Using a Disease Management Program within an Integrated Health System [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/improving-gout-outcomes-using-a-disease-management-program-within-an-integrated-health-system/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-gout-outcomes-using-a-disease-management-program-within-an-integrated-health-system/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology